FDAnews Drug Daily Bulletin

INTELLIPHARMACEUTICS ANNOUNCES AGREEMENT FOR DEVELOPMENT OF CONTROLLED RELEASE PRODUCT

Dec. 21, 2005
A A

IntelliPharmaCeutics Corp. of Toronto, Ontario is pleased to announce that it has entered into an agreement with ratiopharm inc. of Mississauga, Ontario, for the development of a generic, controlled release drug product for the Canadian market. IntelliPharmaCeutics Corp. is a Canadian specialty drug development company, and operating affiliate of IntelliPharmaCeutics Ltd., (Delaware). ratiopharm develops, manufactures, markets and distributes generic pharmaceutical products in Canada.

Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1129609XSL_NEWSML_TO_NEWSML_WEB.xml)